出典:Wikipedia
出典:『Wikipedia』 (2011/08/07 12:46 UTC 版)
Efaproxiral (INN) is an allosteric effector of hemoglobin. It increases the oxygen-carrying capacity of hemoglobin, and is normally used to increase the efficacy of certain chemotherapy drugs which have reduced efficacy against hypoxic (oxygen-poor) tumours, and can thus be made more effective by increasing oxygenation of the tumour tissues. However this increased oxygenation of tissues can also produced enhanced exercise capacity, which has led to efaproxiral being added to the World Anti-Doping Agency banned list for athletes in competition.